Home › Spinal Cord Injuries › NCT07210437

Longitudinal Autonomic Characterization as a Predictor for Secondary Medical Complications Post-SCI

Who can join

Ages 18 to 75 · All sexes

Inclusion criteria

* 18-75 years old
* Spinal cord injury with neurological level of injury from C6-T12
* ASIA Impairment Scale A-D.
* Either acute SCI \<3 months prior (n=10) or chronic SCI (\>1 year since injury, n=8).

Exclusion criteria

* Symptoms of cardiovascular (including, but not limited to: hypertension, stroke, chest pain, etc.), respiratory, peripheral neurological or autonomic disease (particularly diabetes mellitus requiring treatment);
* Women who are pregnant or lactating
* Taking or being administered a medication known to potentially have adverse interactions with phenylephrine
* In the judgement of the principal investigator, any illness or condition that will interfere with the patient's ability to comply with the protocol, compromise patient safety, or interfere with the interpretation of the study results.

About the study

The purpose of this research is to learn about how the body is able to balance changes in blood pressure, how that changes over time, and how these changes impact a participant's risk of developing medical problems.

What is being tested

• Tests of sympathetic inhibition (diagnostic test)
• Tests of above level sympathetic activation (diagnostic test)
• Testing of below level sympathetic activation (diagnostic test)

Sponsor: Mayo Clinic · Participants: 18 · Started: Jan 31, 2026

Contact the study team

• Erin Lund · Phone: 507-284-9298

Official record on ClinicalTrials.gov — NCT07210437

Locations in the U.S.

Conditions

• Spinal Cord Injuries

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.